Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

14.20

-0.29 (-2.00%)

Dec 5, 2025, 4:00 PM EST - Market closed

Amylyx Pharmaceuticals Employees

Amylyx Pharmaceuticals had 123 employees as of December 31, 2024. The number of employees decreased by 261 or -67.97% compared to the previous year.

Employees

123

Change (1Y)

-261

Growth (1Y)

-67.97%

Revenue / Employee

n/a

Profits / Employee

-$1,213,675

Market Cap

1.56B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	123	-261	-67.97%
Dec 31, 2023	384	122	46.56%
Dec 31, 2022	262	57	27.80%
Dec 31, 2021	205	171	502.94%
Dec 31, 2020	34	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

AMLX News

1 day ago - Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial - Business Wire
2 days ago - Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
3 days ago - With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? - The Motley Fool
7 days ago - HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
19 days ago - This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead - The Motley Fool
22 days ago - Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX - Business Wire
4 weeks ago - Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2025 Earnings Call Transcript - Seeking Alpha
4 weeks ago - Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results - Business Wire